KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Invested Capital (2016 - 2025)

Historic Invested Capital for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $534.1 million.

  • Dynavax Technologies' Invested Capital fell 2161.48% to $534.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $534.1 million, marking a year-over-year decrease of 2161.48%. This contributed to the annual value of $596.8 million for FY2024, which is 406.27% down from last year.
  • Dynavax Technologies' Invested Capital amounted to $534.1 million in Q3 2025, which was down 2161.48% from $494.2 million recorded in Q2 2025.
  • Over the past 5 years, Dynavax Technologies' Invested Capital peaked at $681.4 million during Q3 2024, and registered a low of $67.6 million during Q3 2021.
  • Its 5-year average for Invested Capital is $459.6 million, with a median of $534.1 million in 2025.
  • Per our database at Business Quant, Dynavax Technologies' Invested Capital surged by 74372.46% in 2021 and then tumbled by 2312.94% in 2025.
  • Over the past 5 years, Dynavax Technologies' Invested Capital (Quarter) stood at $222.4 million in 2021, then skyrocketed by 161.28% to $581.0 million in 2022, then rose by 7.07% to $622.1 million in 2023, then dropped by 4.06% to $596.8 million in 2024, then fell by 10.5% to $534.1 million in 2025.
  • Its last three reported values are $534.1 million in Q3 2025, $494.2 million for Q2 2025, and $530.9 million during Q1 2025.